Tamara A Seymour Net Worth & Insider Trades

Tamara A Seymour - Director, Kempharm, Inc

As of June 30, 2022

What is Tamara A Seymour's Net Worth?

The current estimated net worth of Kempharm, Inc's Director, Tamara A Seymour, is estimated to be about $14.03K . Tamara A Seymour owns about 200 units of Kempharm, Inc common stock. In the last month at Kempharm, Inc, Tamara A Seymour has sold an estimated value of $0 worth.

What is Tamara A Seymour's Past Insider Trading?

Tamara A Seymour's largest purchase order was 200 units , worth over $974 on May 24, 2022. In total, Tamara A Seymour has made about 2 transactions over a month of their time at Kempharm, Inc. Tamara A Seymour usually trades in May and June, with the busiest year in 2022.

Tamara A Seymour

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Tamara A Seymour's' Mailing Address?

  • Mailing address is C/o Signal Genetics, Inc. 5740 Fleet Street Carlsbad CA 92008 CA

Kempharm, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Total
Travis C. Mickle, Ph.D. 2020 $530,450 - $291,748 $134,381 $11,400 $967,979
Travis C. Mickle, Ph.D. 2019 $527,875 - - $825,807 $6,492 $1,360,174
Sven Guenther, Ph.D. 2020 $374,792 $10,000 $124,285 $51,193 $13,061 $563,331
Sven Guenther, Ph.D. 2019 $363,875 - - $311,906 $11,950 $687,731
R. LaDuane Clifton, CPA 2020 $350,200 - $134,827 $51,193 $4,894 $541,114
R. LaDuane Clifton, CPA 2019 $348,500 - - $311,906 $4,081 $664,487
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774921010498/kmph20210429_def14a.htm

What are Kempharm, Inc's Past Insider Trades?

Kempharm, Inc's most recent insider trade came on October 3, 2022 by R. Laduane Clifton who bought 1,000 units worth $5.98K . In the last 7 years, insiders at Kempharm, Inc have sold an estimated value of $15.5K and bought an estimated value of $9.39M worth of shares. Insider trading is most common in May, with the busiest year in 2019. The most active traders at the company are R. Laduane Clifton, CFO,  Travis C Mickle, President & CEO,  and David S Tierney, Director .

KEMPHARM, INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1